Ivosidenib Market Analysis by Indication (Acute Myeloid Leukemia (AML), Cholangiocarcinoma, Other Indications), By Dosage Form (Tablet, Others), By Distribution Channel (Hospitals, Specialty Clinics, Online Pharmacies, Retail Pharmacies), By End-User (Hospitals & Clinics, Research Institutes, Others) and by Region: Global Forecast, 2024 - 2034.
- PUBLISHED ON
- 2024-08-23
- NO OF PAGES
- 220
- CATEGORY
- Healthcare & Life Sciences
Market Overview
The Ivosidenib market is predicted to
develop at a compound annual growth rate (CAGR) of xx% from 2024 to 2034, when it
is projected to reach USD xx Billion, based on an average growth pattern. The
market is estimated to reach a value of USD xx Billion in 2024.
SOURCE: We Market Research
AML and
cholangiocarcinoma are two tumors that can be treated with ivosidenib, a
targeted cancer medication. It selectively blocks IDH1 gene alterations, which
can cause these tumors' aberrant cell proliferation. Ivosidenib helps restore
normal cell differentiation by targeting the IDH1 mutation, which slows or
stops the progression of cancer. It offers a customized treatment plan and is
recommended for patients with proven IDH1-mutated tumors. By concentrating on
the genetic makeup of a patient's tumor, this medication advances targeted
therapy and enables more efficient and customized cancer treatment.
The growing prevalence of diseases like acute myeloid leukemia (AML) and cholangiocarcinoma with IDH1 mutations is driving the global Ivosidenib market. This targeted therapy is becoming more and more in demand as precision medicine and genetic testing advance. Its market presence is increased by regulatory approvals from organizations such as the FDA and EMA, and further research could lead to a wider range of medicinal applications. Good reimbursement practices in strategic areas also improve uptake and accessibility. All of these elements work together to fuel the rising demand for ivosidenib as a customized cancer treatment on a worldwide scale.
Market Scope
|
Report Attributes |
Description |
|
Market Size in 2024 |
USD xx Billion |
|
Market
Forecast in 2034 |
USD xx Billion |
|
CAGR % 2024-2034 |
xx% |
|
Base
Year |
2023 |
|
Historic Data |
2016-2022 |
|
Forecast
Period |
2024-2034 |
|
Report USP
|
Production,
Consumption, company share, company heatmap, company production capacity,
growth factors and more |
|
Segments
Covered |
By
Indication, By Dosage Form, By Distribution Channel, By End-User and By
Region |
|
Regional Scope |
North America,
Europe, APAC, South America and Middle East and Africa |
|
Country
Scope |
U.S.; Canada;
U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia;
China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico;
Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Ivosidenib Industry: Dynamics & Restrains
Market opportunity:
We Market
Research: Ivosidenib Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Ivosidenib Segmentation
Market- By Indication Analysis
By Indication, the Ivosidenib Market is Categories into Acute Myeloid Leukemia (AML), Cholangiocarcinoma, Other Indications. The Acute Myeloid Leukemia (AML) segment accounts for the largest share of around 86% in 2024.
The segment for AML dominates the market
due to the significant prevalence of this condition and the urgent need for
effective treatments. Ivosidenib is particularly effective for patients with
AML who have a specific mutation in the IDH1 gene, making it a targeted
therapy. The high incidence of AML and the critical nature of the disease
contribute to the dominance of this segment in the market.
The
following segments are part of an in-depth analysis of the global Ivosidenib
market:
|
Market
Segments |
|
|
By
Dosage Form |
·
Tablet ·
Others |
|
By
Distribution Channel |
·
Hospitals ·
Specialty Clinics ·
Online Pharmacies ·
Retail Pharmacies |
|
By
End-User |
·
Hospitals & Clinics ·
Research Institutes ·
Others |
Ivosidenib Industry: Regional Analysis
North America Market Forecast
North America dominates the Ivosidenib Market with the highest revenue generating market with share of more than 48%. Advanced healthcare infrastructure and high healthcare spending fuel market growth. The presence of major pharmaceutical companies and research institutions supports robust R&D, while a favorable regulatory environment, particularly FDA approvals, facilitates the rapid introduction of Ivosidenib for cancer treatment.
Europe Market Statistics
Europe's strong
emphasis on oncology R&D and increasing cancer prevalence drive demand.
Government initiatives and funding for cancer treatment further boost the
market, while EMA approvals ensure standardized access to Ivosidenib across
multiple countries, supporting growth despite stringent regulations.
Asia Pacific Market Forecasts
Asia Pacific is expected to be the fastest-growing regional segment of the Ivosidenib market during the forecast period. In the Asia Pacific region, rapidly growing populations, aging demographics, and increasing cancer awareness are key drivers. Expanding healthcare infrastructure, particularly in emerging economies like China and India, along with rising demand for advanced treatments, position Asia-Pacific as a high-growth region for Ivosidenib.
Key Market Players
·
Agios Pharmaceuticals
1.
Global
Ivosidenib Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Ivosidenib Market Scope
and Market Estimation
1.2.1. Global Ivosidenib Overall Market
Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)
1.2.2. Global Ivosidenib Market Revenue
Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3. Market Segmentation
1.3.1. Indication of Global Ivosidenib
Market
1.3.2. Dosage Form of Global Ivosidenib
Market
1.3.3. Distribution Channel of Global Ivosidenib
Market
1.3.4. End-User of Global Ivosidenib
Market
1.3.5. Region of Global Ivosidenib
Market
2.
Executive Summary
2.1. Market Dynamics
2.1.1. Drivers
2.1.2. Limitations
2.1.3. Opportunities
2.1.4. Impact Analysis of Drivers and
Restraints
2.2. Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.3. Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitutes
2.4.4. Threat of New Entrants
2.4.5. Competitive Rivalry
2.5. Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.
Global Ivosidenib Market Estimates & Historical Trend Analysis (2019 -
2023)
4.
Global Ivosidenib Market Estimates & Forecast Trend Analysis, by
Indication
4.1. Global Ivosidenib Market Revenue
(US$ Mn) Estimates and Forecasts, by Indication, 2019 to 2034
4.1.1. Acute Myeloid Leukemia (AML)
4.1.2. Cholangiocarcinoma
4.1.3. Other Indications
5.
Global Ivosidenib Market Estimates & Forecast Trend Analysis, by
Dosage Form
5.1. Global Ivosidenib Market Revenue
(US$ Mn) Estimates and Forecasts, by Dosage Form, 2019 to 2034
5.1.1. Tablet
5.1.2. Others
6.
Global Ivosidenib Market Estimates & Forecast Trend Analysis, by
Distribution Channel
6.1. Global Ivosidenib Market Revenue
(US$ Mn) Estimates and Forecasts, by Distribution
Channel, 2019 to 2034
6.1.1. Hospitals
6.1.2. Specialty Clinics
6.1.3. Online Pharmacies
6.1.4. Retail Pharmacies
7.
Global Ivosidenib Market Estimates & Forecast Trend Analysis, by
End-User
7.1. Global Ivosidenib Market Revenue
(US$ Mn) Estimates and Forecasts, by End-User, 2019 to 2034
7.1.1. Hospitals & Clinics
7.1.2. Research Institutes
7.1.3. Others
8.
Global Ivosidenib Market Estimates & Forecast Trend Analysis,
by region
8.1. Global Ivosidenib Market Revenue
(US$ Mn) Estimates and Forecasts, by region, 2019 to 2034
8.1.1. North America
8.1.2. Europe
8.1.3. Asia Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9.
North
America Ivosidenib Market: Estimates & Forecast Trend Analysis
9.1.
North
America Ivosidenib Market Assessments & Key Findings
9.1.1. North America Ivosidenib Market
Introduction
9.1.2. North America Ivosidenib Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
9.1.2.1. By Indication
9.1.2.2. By Dosage Form
9.1.2.3. By Distribution
Channel
9.1.2.4. By End-User
9.1.2.5. By Country
9.1.2.5.1. The U.S.
9.1.2.5.2. Canada
9.1.2.5.3. Mexico
10. Europe Ivosidenib
Market: Estimates & Forecast Trend
Analysis
10.1. Europe Ivosidenib Market
Assessments & Key Findings
10.1.1. Europe Ivosidenib Market
Introduction
10.1.2. Europe Ivosidenib Market Size
Estimates and Forecast (US$ Million) (2019 – 2034)
10.1.2.1. By Indication
10.1.2.2. By Dosage Form
10.1.2.3. By Distribution
Channel
10.1.2.4. By End-User
10.1.2.5. By Country
10.1.2.5.1. Germany
10.1.2.5.2. U.K.
10.1.2.5.3. France
10.1.2.5.4. Italy
10.1.2.5.5. Spain
10.1.2.5.6. Russia
10.1.2.5.7. Rest of Europe
11. Asia Pacific Ivosidenib
Market: Estimates & Forecast Trend
Analysis
11.1. Asia Pacific Market Assessments
& Key Findings
11.1.1. Asia Pacific Ivosidenib Market
Introduction
11.1.2. Asia Pacific Ivosidenib Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
11.1.2.1. By Indication
11.1.2.2. By Dosage Form
11.1.2.3. By Distribution
Channel
11.1.2.4. By End-User
11.1.2.5. By Country
11.1.2.5.1. China
11.1.2.5.2. Japan
11.1.2.5.3. India
11.1.2.5.4. Australia
11.1.2.5.5. South Korea
11.1.2.5.6. ASEAN
11.1.2.5.7. Rest of Asia Pacific
12. Middle East & Africa Ivosidenib
Market: Estimates & Forecast Trend
Analysis
12.1. Middle East & Africa Market
Assessments & Key Findings
12.1.1. Middle
East & Africa Ivosidenib
Market Introduction
12.1.2. Middle
East & Africa Ivosidenib
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
12.1.2.1. By Indication
12.1.2.2. By Dosage Form
12.1.2.3. By Distribution
Channel
12.1.2.4. By End-User
12.1.2.5. By Country
12.1.2.5.1. U.A.E.
12.1.2.5.2. Saudi Arabia
12.1.2.5.3. Egypt
12.1.2.5.4. South Africa
12.1.2.5.5. Rest of Middle East & Africa
13. South America
Ivosidenib Market: Estimates &
Forecast Trend Analysis
13.1. South America Market Assessments
& Key Findings
13.1.1. South America Ivosidenib Market
Introduction
13.1.2. South America Ivosidenib Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
13.1.2.1. By Indication
13.1.2.2. By Dosage Form
13.1.2.3. By Distribution
Channel
13.1.2.4. By End-User
13.1.2.5. By Country
13.1.2.5.1. Brazil
13.1.2.5.2. Argentina
13.1.2.5.3. Colombia
13.1.2.5.4. Rest of South America
14. Competition Landscape
14.1. Global Ivosidenib Market
Competition Matrix & Benchmarking, by Leading Players / Innovators /
Emerging Players / New Entrants
14.2. Global Ivosidenib Market
Competition White Space Analysis, By End-user
14.3. Global Ivosidenib Market
Competition Heat Map Analysis, By End-user
14.4. Global Ivosidenib Market
Concentration & Company Market Shares (%) Analysis, 2022
15. Company Profiles
15.1.
Agios Pharmaceuticals.
15.1.1. Company Overview & Key Stats
15.1.2. Financial Performance & KPIs
15.1.3. Product Portfolio
15.1.4. Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned below
16. Research
Methodology
16.1. External Transportations /
Databases
16.2. Internal Proprietary Database
16.3. Primary Research
16.4. Secondary Research
16.5. Assumptions
16.6. Limitations
16.7. Report FAQs
17. Research Findings & Conclusion
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size of Ivosidenib Market in 2024?
Ivosidenib Market was valued at USD xx Billion in 2024.
What is the growth rate for the Ivosidenib Market?
Ivosidenib Market size will increase at approximate CAGR of xx% during the forecasted period.
Which are the top companies operating within the market?
Major companies operating within the Ivosidenib Market Are Agios Pharmaceuticals and Others.
Which region dominates the Ivosidenib Market?
North America dominates the market with an active share of 48%.
}})
Select a license type that suits your business needs
US $3499
Only Three Thousand Four Hundred Ninety Nine US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4499
Only Four Thousand Four Hundred Ninety Nine US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5499
Only Five Thousand Four Hundred Ninety Nine US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI